Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?
Open Access
- 13 May 2021
- journal article
- review article
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 2, 100027
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- NAD+ and sirtuins in aging and diseaseTrends in Cell Biology, 2014
- The clinical consequences of an ageing world and preventive strategiesBest Practice & Research Clinical Obstetrics & Gynaecology, 2013
- Antioxidant Supplements to Prevent MortalityJAMA, 2013
- Are "Anti-Aging Medicine" and "Successful Aging" Two Sides of the Same Coin? Views of Anti-Aging PractitionersThe Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2013
- NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategiesImmunity & Ageing, 2013
- Translating advances from the basic biology of aging into clinical applicationExperimental Gerontology, 2013
- Population aging, the dependency burden, and challenges facing preventive medicinePreventive Medicine, 2012
- Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosisAtherosclerosis, 2011
- Extension of Human Cell Lifespan by Nicotinamide PhosphoribosyltransferaseJournal of Biological Chemistry, 2007
- Can We Delay Aging? The Biology and Science of AgingAnnals of the New York Academy of Sciences, 2005